Neurology/Psychiatric Neumora’s M4 receptor positive allosteric modulator enters clinic for schizophrenia Nov. 27, 2023 Neumora Therapeutics Inc. has announced IND clearance and initiation of a phase I study of NMRA-266 in healthy adults. Read More